(Q53338848)

English

An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.

scientific article published on 18 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

author name string

Fan Y

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

Gélinas C

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

language of work or name

0 references

publication date

18 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

26

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

27

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

4038-4043

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210164

0 references

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Transactivation of gene expression by nuclear and cytoplasmic rel proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Oncogenic transformation by vrel requires an amino-terminal activation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Tumor Necrosis Factor-α Activation of NF-κB Requires the Phosphorylation of Ser-471 in the Transactivation Domain of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

IkB-alpha-specific transcript regulation by the C-terminal end of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210164

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53338848&oldid=2085746505"